Improving Stem Cell Treatment with Novel Drug Compound

One of the primary limitations of stem cell treatment and the subject of ongoing research is the challenge of directing stem cells to their necessary destination in the body which has been a subject of ongoing research. Prior studies have discovered that stem cells are drawn to inflammation in the body, however, using this as a therapeutic lure still poses risks. Thus, researchers continue their search for tools that would aid stem cells in their migration and conversion into specific types of cells necessary for optimal treatment. The ability to do so would have a wide range of implications for regenerative medicine as well as the treatment of disorders in which inflammatory signals fade over time, such as chronic spinal cord injury, stroke, or conditions in which the role of inflammation remains unknown.  Continue reading

Cognitive Behavioral Therapy for Insomnia 

Up to 32.5% of all adults in the United States report sleeping for less than seven hours per night on average despite needing between seven and nine hours of sleep. The problem of insomnia affects between 10% and 35% of adults, varying in duration, severity, and treatment outcomes. For some, insomnia can present as a brief problem while other patients may struggle with severe, chronic insomnia – both can have a negative effect on overall health, increasing the risk of mental health disorders, lowering quality of life, and raising blood pressure.

Sleeping medications are often prescribed to help patients resume a normal, healthy sleep schedule although these risk dependency and may lead to unwanted side effects. Cognitive behavioral therapy for insomnia, also known as CBT-I, is short, structured, and evidence-based approach to combating insomnia that can benefit the majority of patients with sleep problems. CBT-I can be beneficial for individuals with primary insomnia as well as those with chronic pain and mental health disorders.

Continue reading

Everything You Need to Know About the Endocannabinoid System 

First identified in the early 1990s, the endocannabinoid system (ECS) has emerged as an important neuromodulatory system over recent years. The complex cell-signaling system regulates and controls many bodily functions, active in the body without the use of cannabis. A growing understanding of the ECS and the role it plays in a wide-range of biological pathways has placed it at the center of increasing international research and drug development efforts. As a result, the burgeoning field of ECS-targeted therapeutics and their approved applications in clinical practice are likely to expand exponentially in the near future.

Continue reading